Kevin Lind
InvestorBoard Member at Avalo Therapeutics · Vice President, Finance & Administration at Volta
Greater Boston
About
Seasoned biotechnology executive with over 20 years of leadership experience. Most recently President, CEO, and Board Member of Longboard Pharmaceuticals, leading its transformation and $2.6 billion acquisition by H. Lundbeck A/S in 2024. Previously Executive Vice President and CFO at Arena Pharmaceuticals. Career includes investment banking at Lehman Brothers and healthcare investing at TPG, with over a billion dollars in capital raised.
Experience
- VoltaVice President, Finance & Administrationcurrent2020 — present
- VoltaControllercurrent2018 — presentHalifax, Nova Scotia
- Financial and Operations ConsultantSelf Employedcurrent2013 — present
- Merrex Gold Inc.Director, Corporate Affairs2006 — 2013Bedford, Nova Scotia
- Amirix Systems Inc.Corporate Secretary1999 — 2006
Skills & more
Bookkeeping1Investor Relations19Strategic Planning18Business Strategy14Mining12Change Management7Strategic Communications8Gold7Project Management6Mergers & Acquisitions7Management6Venture Capital3
+5 more
Operations ManagementNegotiationProject PlanningBusiness PlanningEntrepreneurshipFrom Kevin's professional profile.
Colleagues at Avalo Therapeutics
Aaron Kantoff
Board Member at Avalo Therapeutics
Aaron Kantoff
Managing Partner at Scion Life Sciences
Amy Conrad
Senior Events Manager at Volta Labs
Amy Conrad
Director of Events & Community Engagement at Volta
Ashley Ivanowicz
Senior Vice President, Human Resources at Avalo Therapeutics
Chris Sullivan
Chief Financial Officer at Avalo Therapeutics
Colleen Matkowski
Senior Vice President, Global Regulatory Affairs and Quality Assurance at Avalo Therapeutics
Dino C. Miano
Senior Vice President, CMC and Technical Operations at Avalo Therapeutics
Frequently asked questions
- Who is Kevin Lind?
- Seasoned biotechnology executive with over 20 years of leadership experience. Most recently President, CEO, and Board Member of Longboard Pharmaceuticals, leading its transformation and $2.6 billion acquisition by H. Lundbeck A/S in 2024. Previously Executive Vice President and CFO at Arena Pharmaceuticals. Career includes investment banking at Lehman Brothers and healthcare investing at TPG, with over a billion dollars in capital raised.
- Where does Kevin Lind work?
- Kevin Lind is Board Member at Avalo Therapeutics.